Inhibrx Biosciences, Inc. (INBX) stock
INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$69.06−5.12 (-6.90%)
Close on Nov 18, 2026Market cap $1.02BP/E –Yield –
Inhibrx Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Inhibrx Biosciences's market cap was $1.33B on Nov 11, 2026, against $1.22B a year earlier. Over the last 5 years it ranged from $110.74M to $1.88B, with a median of $245.56M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.33B | +16.3% |
| 2025 | Dec 31, 2025 | $1.15B | +413.8% |
| 2024 | Dec 31, 2024 | $222.93M | -50.4% |
| 2023 | Dec 29, 2023 | $449.26M | +86.6% |
| 2022 | Dec 30, 2022 | $240.78M | -41.9% |
| 2021 | Dec 31, 2021 | $414.13M | +33.2% |
| 2020 | Dec 31, 2020 | $310.83M | – |
See a number that looks wrong?